Generic-Drug Makers Get EU Approval for Virus Cooperation (1)

Generic-drug makers from Mylan NV to Teva Pharmaceutical Industries Ltd. won European Union antitrust clearance to cooperate on supplies of critical hospital medicines amid the Covid-19 pandemic.

The European Commission sent the Medicines for Europe group of generic pharmaceutical companies a so-called comfort letter to assure them they could join forces without the risk of heavy cartel fines.

“To avoid the risk of shortages of essential and scarce products and services because of the unprecedented surge in demand due to the pandemic, we need businesses to cooperate and do it in line with European competition rules,” Margrethe Vestager, the ...